相关实验视频

Updated: Jun 11, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

专注于CD8⁺ T细胞表型:改善固体瘤治疗方法

Zhouchi Yao¹, Yayun Zeng², Cheng Liu¹

¹Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Laboratory of Structural Immunology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.

Journal of experimental & clinical cancer research : CR

|September 28, 2024

概括

增强CD8+T细胞功能是对抗固体瘤的关键. 本综述探讨了促进T细胞受体 (TCR) 信号传递,抗原识别,瘤定位和代谢途径以改善抗瘤免疫力的新策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

CD8+ T 细胞对于抗瘤免疫对于固体瘤至关重要.
了解T细胞活动和寿命对于有效的癌症免疫疗法至关重要.

研究的目的:

审查用于增强CD8+T细胞功能对抗固体瘤的新策略.
突出优化T细胞受体 (TCR) 表达和抗原识别的方法.
讨论改善瘤微环境中的T细胞持久性和有效性的方法.

主要方法:

关于T细胞工程和免疫疗法的最新进展的综述.
专注于优化TCR信号传递,抗原识别和T细胞定位.
探索扭转T细胞耗尽和重编程T细胞代谢的策略.
讨论影响T细胞抗瘤反应的表观遗传修饰.

主要成果:

优化TCR表达和抗原识别可以增强T细胞向瘤的目标.
改善T细胞定位和逆转疲劳对于持续的抗瘤活性至关重要.
重新编程T细胞代谢和表观遗传环境可以提高有效性和持久性.
最近的进展为下一代癌症免疫疗法提供了有希望的途径.

结论:

有多种策略可以增强CD8+T细胞介导的抗瘤免疫力.
准TCR信号传导,新陈代谢和表观遗传学对癌症免疫治疗具有重大潜力.
对这些领域的进一步研究将引导开发更有效的固体瘤治疗方法.

关键词:

在 CD8+ T 细胞中.工程T细胞受体-T细胞的工程T细胞受体.基因编辑基因编辑免疫检查站检查站免疫系统的重编程免疫治疗是一种免疫疗法.代谢重编程是一种代谢重编程.固体瘤是一个固体瘤.T细胞重定向的重定向

更多相关视频

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...